Literature DB >> 33477467

Toxic Shock Syndrome Toxin 1 Induces Immune Response via the Activation of NLRP3 Inflammasome.

Lianci Peng1, Jiali Jiang1,2, Tingting Chen1, Dongyi Xu1, Fengqing Hou1, Qingyuan Huang1, Yuanyi Peng1, Chao Ye1, Dong-Liang Hu1,3, Rendong Fang1,4.   

Abstract

Staphylococcus aureus is a Gram-positive opportunistic pathogen which causes infections in a variety of vertebrates. Virulence factors are the main pathogenesis of S. aureus as a pathogen, which induce the host's innate and adaptive immune responses. Toxic shock syndrome toxin 1 (TSST-1) is one of the most important virulence factors of S. aureus. However, the role of nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 3 (NLRP3) in TSST-1-induced innate immune response is still unclear. Here, purified recombinant TSST-1 (rTSST-1) was prepared and used to stimulate mouse peritoneal macrophages. The results showed that under the action of adenosine-triphosphate (ATP), rTSST-1 significantly induced interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) production in mouse macrophages and the production was dose-dependent. In addition, rTSST-1+ATP-stimulated cytokine production in macrophage depends on the activation of toll like receptor 4 (TLR4), but not TLR2 on the cells. Furthermore, the macrophages of NLRP3-/- mice stimulated with rTSST-1+ATP showed significantly low levels of IL-1β production compared to that of wild-type mice. These results demonstrated that TSST-1 can induce the expression of inflammatory cytokines in macrophages via the activation of the TLR4 and NLRP3 signaling pathways. Our study provides new information about the mechanism of the TSST-1-inducing host's innate immune responses.

Entities:  

Keywords:  Staphylococcal toxins; inflammasome; interleukin-1β; toxic shock syndrome toxin 1

Mesh:

Substances:

Year:  2021        PMID: 33477467      PMCID: PMC7829800          DOI: 10.3390/toxins13010068

Source DB:  PubMed          Journal:  Toxins (Basel)        ISSN: 2072-6651            Impact factor:   4.546


  35 in total

1.  Subunit composition of a bicomponent toxin: staphylococcal leukocidin forms an octameric transmembrane pore.

Authors:  George Miles; Liviu Movileanu; Hagan Bayley
Journal:  Protein Sci       Date:  2002-04       Impact factor: 6.725

Review 2.  The nucleic acid-sensing inflammasomes.

Authors:  Tsan Sam Xiao
Journal:  Immunol Rev       Date:  2015-05       Impact factor: 12.988

3.  The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus.

Authors:  Yue Zhao; Jieling Yang; Jianjin Shi; Yi-Nan Gong; Qiuhe Lu; Hao Xu; Liping Liu; Feng Shao
Journal:  Nature       Date:  2011-09-14       Impact factor: 49.962

4.  One-way synergistic effect of low superantigen concentrations on lipopolysaccharide-induced cytokine production.

Authors:  J Luhm; H Kirchner; L Rink
Journal:  J Interferon Cytokine Res       Date:  1997-04       Impact factor: 2.607

Review 5.  Bacterial Sphingomyelinases and Phospholipases as Virulence Factors.

Authors:  Marietta Flores-Díaz; Laura Monturiol-Gross; Claire Naylor; Alberto Alape-Girón; Antje Flieger
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-15       Impact factor: 11.056

6.  Staphylococcal enterotoxins condition cells of the innate immune system for Toll-like receptor 4 stimulation.

Authors:  Robert J Rossi; Guruprasaadh Muralimohan; Joseph R Maxwell; Anthony T Vella
Journal:  Int Immunol       Date:  2004-10-25       Impact factor: 4.823

7.  Characterization of infecting strains and superantigen-neutralizing antibodies in Staphylococcus aureus bacteremia.

Authors:  Dorothee Grumann; Eeva Ruotsalainen; Julia Kolata; Pentti Kuusela; Asko Järvinen; Vesa P Kontinen; Barbara M Bröker; Silva Holtfreter
Journal:  Clin Vaccine Immunol       Date:  2011-01-19

Review 8.  Staphylococcus aureus and its food poisoning toxins: characterization and outbreak investigation.

Authors:  Jacques-Antoine Hennekinne; Marie-Laure De Buyser; Sylviane Dragacci
Journal:  FEMS Microbiol Rev       Date:  2011-11-08       Impact factor: 16.408

9.  Vaccination with nontoxic mutant toxic shock syndrome toxin 1 protects against Staphylococcus aureus infection.

Authors:  Dong-Liang Hu; Katsuhiko Omoe; Sanae Sasaki; Hiroshi Sashinami; Hirotake Sakuraba; Yuichi Yokomizo; Kunihiro Shinagawa; Akio Nakane
Journal:  J Infect Dis       Date:  2003-08-14       Impact factor: 5.226

10.  Staphylococcal superantigen (TSST-1) mutant analysis reveals that t cell activation is required for biological effects in the rabbit including the cytokine storm.

Authors:  Norbert Stich; Martina Waclavicek; Nina Model; Martha M Eibl
Journal:  Toxins (Basel)       Date:  2010-09-09       Impact factor: 4.546

View more
  5 in total

1.  Essential Role of NLRP3 Inflammasome in Mediating IL-1β Production and the Pathobiology of Staphylococcus aureus Endophthalmitis.

Authors:  Ajay Kumar; Pawan Kumar Singh; Zeeshan Ahmed; Sukhvinder Singh; Ashok Kumar
Journal:  Infect Immun       Date:  2022-04-11       Impact factor: 3.609

2.  Aggregatibacter actinomycetemcomitans Leukotoxin Activates the NLRP3 Inflammasome and Cell-to-Cell Communication.

Authors:  Peyman Kelk; Nick Sina Moghbel; Josefine Hirschfeld; Anders Johansson
Journal:  Pathogens       Date:  2022-01-26

3.  Functional and Immunological Studies Revealed a Second Superantigen Toxin in Staphylococcal Enterotoxin C Producing Staphylococcus aureus Strains.

Authors:  Andreas Roetzer; Nina Model; Jakob Laube; Yvonne Unterhumer; Guenter Haller; Martha M Eibl
Journal:  Toxins (Basel)       Date:  2022-08-29       Impact factor: 5.075

Review 4.  Inflammasomes in Alveolar Bone Loss.

Authors:  Yang Li; Junqi Ling; Qianzhou Jiang
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

5.  Staphylococcal Enterotoxin A Induces Intestinal Barrier Dysfunction and Activates NLRP3 Inflammasome via NF-κB/MAPK Signaling Pathways in Mice.

Authors:  Chunmei Liu; Kunmei Chi; Meng Yang; Na Guo
Journal:  Toxins (Basel)       Date:  2022-01-01       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.